Piperidin-4-yl azetidine derivatives as JAK1 inhibitors

BNRE20190001BUndetermined Publication Date: 2019-01-28INCYTE HOLDINGS CORP

View PDF 0 Cites 0 Cited by

Patent Information

Application Number: BNRE20190001
Authority / Receiving Office: BN · BN
Patent Type: Patents
Current Assignee / Owner
Priority Date: 2010-11-19
Filing Date: 2011-03-09
Publication Date: 2019-01-28
Estimated Expiration: 2031-03-09

Application Information

Patent Timeline

19 Nov 2010

Priority

09 Mar 2011

Application

BNRE20190001

28 Jan 2019

Publication

BNRE20190001B

IPC: A61K; A61P; C07D

Inventors: HUANG TAISHENG; XUE CHU-BIAO

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Smart Images

Figure IMAGE_001

Patent Text Reader

Abstract

The present invention provides piperidin-4-yl azetidine derivatives, as well as their compositions and methods of use, that modulate the activity of Janus kinase 1 (JAK1) and are useful in the treatment of diseases related to the activity of JAK1 including, for example, inflammatory disorders, autoimmune disorders, cancer, and other diseases.

Need to check novelty before this filing date? Find Prior Art